Literature DB >> 28413670

Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma.

Qun-Xiong Pan1, Zi-Jian Su1, Jian-Hua Zhang1, Chong-Ren Wang1, Shao-Ying Ke1.   

Abstract

High Glasgow Prognostic Score (GPS) has been associated with poor prognosis in patients with lung, ovarian, colorectal and renal cancer, as well as hepatocellular carcinoma. The aim of this study was to investigate the prognostic value of GPS in patients with intrahepatic cholangiocarcinoma (ICC) undergoing partial hepatectomy. A total of 72 patients with pathologically confirmed ICC were classified according to their GPS scores assigned based on the preoperative levels of C-reactive protein (CRP) and albumin. Their clinicopathological data were retrospectively assessed using univariate and multivariate analysis to determine their association with overall survival and recurrence. High GPS scores in ICC patients were associated with preoperative levels of CRP (P<0.001) and albumin (P<0.001), frequency of ascites accumulation (P=0.035), lymph node metastasis (P=0.002) and tumour size (P=0.005). On univariate analysis, preoperative levels of CRP (P<0.001), albumin (P=0.016) and carbohydrate antigen 19-9 (P=0.038), hepatitis B virus (HBV) positivity (P=0.009), occurrence of lymph node metastasis (P=0.001), Child-Pugh class B (P=0.013) and high tumour-node-metastasis (TNM) stage (P=0.002) were found to be associated with the 1- and 3-year overall survival. Multivariate analysis suggested that GPS score (HR=2.037, 95% CI: 1.092-3.799, P=0.025), TNM classification (HR=2.000, 95% CI: 1.188-3.367, P=0.009) and HBV positivity (HR=0.559 95% CI: 0.328-0.953, P=0.032) were independently associated with patient survival. High GPS scores also predicted ICC recurrence. In conclusion, our results demonstrated that GPS may serve as an independent marker of prognosis in patients with ICC following partial hepatectomy.

Entities:  

Keywords:  Glasgow Prognostic Score; intrahepatic cholangiocarcinoma; prognostic marker

Year:  2017        PMID: 28413670      PMCID: PMC5374901          DOI: 10.3892/mco.2017.1166

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  69 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism.

Authors:  Daisaku Yamada; Sumera Rizvi; Nataliya Razumilava; Steven F Bronk; Jaime I Davila; Mia D Champion; Mitesh J Borad; Jorge A Bezerra; Xin Chen; Gregory J Gores
Journal:  Hepatology       Date:  2015-03-20       Impact factor: 17.425

3.  Prognostic significance of pre- and postoperative glasgow prognostic score for patients with non-small cell lung cancer.

Authors:  Masaki Tomita; Takanori Ayabe; Eiichi Chosa; Kunihide Nakamura
Journal:  Anticancer Res       Date:  2014-06       Impact factor: 2.480

4.  Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection.

Authors:  Hua-Bang Zhou; Hui Wang; Yu-Qiong Li; Shuang-Xi Li; Hao Wang; Dong-Xun Zhou; Qian-Qian Tu; Qing Wang; Shan-Shan Zou; Meng-Chao Wu; He-Ping Hu
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

5.  Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer.

Authors:  Paul Glen; Nigel B Jamieson; Donald C McMillan; Ross Carter; Clem W Imrie; Colin J McKay
Journal:  Pancreatology       Date:  2006-07-13       Impact factor: 3.996

6.  Prognosis of hepatocellular carcinoma: the BCLC staging classification.

Authors:  J M Llovet; C Brú; J Bruix
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

7.  Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virus.

Authors:  Scott M Ward; Prabhjeet Phalora; Daniel Bradshaw; Heike Leyendeckers; Paul Klenerman
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

8.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.

Authors:  Tao Li; Lun-Xiu Qin; Jian Zhou; Hui-Chuan Sun; Shuang-Jian Qiu; Qing-Hai Ye; Lu Wang; Zhao-You Tang; Jia Fan
Journal:  Liver Int       Date:  2013-11-20       Impact factor: 5.828

10.  Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer.

Authors:  Masahide Ikeguchi; Sho-Ichi Urushibara; Ryugo Shimoda; Manabu Yamamoto; Yoshihiko Maeta; Keigo Ashida
Journal:  World J Surg Oncol       Date:  2014-07-15       Impact factor: 2.754

View more
  11 in total

1.  Validity of the Glasgow prognostic score and modified systemic inflamma-tion score in predicting complicated cholecystitis.

Authors:  D O Karakaş; M Yeşiltaş
Journal:  Hippokratia       Date:  2020 Jan-Mar       Impact factor: 0.471

2.  Safety and benefits of major hepatectomy with extrahepatic bile duct resection in older perihilar cholangiocarcinoma patients.

Authors:  Koki Maeda; Naohisa Kuriyama; Takahiro Ito; Kazuyuki Gyoten; Aoi Hayasaki; Takehiro Fujii; Yusuke Iizawa; Yasuhiro Murata; Akihiro Tanemura; Masashi Kishiwada; Shugo Mizuno
Journal:  Langenbecks Arch Surg       Date:  2022-08-23       Impact factor: 2.895

3.  Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients.

Authors:  Jian Feng; Bin Liang; Hang-Yu Zhang; Zhe Liu; Kai Jiang; Xiang-Qian Zhao
Journal:  World J Gastrointest Surg       Date:  2022-05-27

4.  Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.

Authors:  Hyungwoo Cho; Changhoon Yoo; Kyu-Pyo Kim; Jae Ho Jeong; Jihoon Kang; Heung-Moon Chang; Sang Soo Lee; Do Hyun Park; Tae Jun Song; Sung Koo Lee; Myung-Hwan Kim; Han Chu Lee; Young-Suk Lim; Kang Mo Kim; Ju Hyun Shim; Shin Hwang; Gi-Won Song; Deok-Bog Moon; Jae Hoon Lee; Young-Joo Lee; Baek-Yeol Ryoo
Journal:  Invest New Drugs       Date:  2017-12-01       Impact factor: 3.850

5.  The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers.

Authors:  Daisuke Noguchi; Naohisa Kuriyama; Yuki Nakagawa; Koki Maeda; Toru Shinkai; Kazuyuki Gyoten; Aoi Hayasaki; Takehiro Fujii; Yusuke Iizawa; Akihiro Tanemura; Yasuhiro Murata; Masashi Kishiwada; Hiroyuki Sakurai; Shugo Mizuno
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

6.  Preoperative risk grade predicts the long-term prognosis of intrahepatic cholangiocarcinoma: a retrospective cohort analysis.

Authors:  Jianping Zhao; Yao Chen; Jingjing Wang; Jian Wang; Ying Wang; Songshan Chai; Yuxin Zhang; Xiaoping Chen; Wanguang Zhang
Journal:  BMC Surg       Date:  2021-03-06       Impact factor: 2.102

Review 7.  Scoring systems for the management of oncological hepato-pancreato-biliary patients.

Authors:  Alexander W Coombs; Chloe Jordan; Sabba A Hussain; Omar Ghandour
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2022-02-28

8.  Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection.

Authors:  Seogsong Jeong; Bo Zheng; Jian Wang; Jiachang Chi; Ying Tong; Lei Xia; Ning Xu; Jianjun Zhang; Xiaoni Kong; Jinyang Gu; Qiang Xia
Journal:  Int J Biol Sci       Date:  2017-09-21       Impact factor: 6.580

9.  Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma.

Authors:  Chen Zheng; Shuaibin Liu; Jiexiong Feng; Xiang Zhao
Journal:  Cancer Manag Res       Date:  2020-04-01       Impact factor: 3.989

10.  Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.

Authors:  Tokuji Ito; Hiroji Shinkawa; Shigekazu Takemura; Shogo Tanaka; Takayoshi Nishioka; Toru Miyazaki; Atsushi Ishihara; Shoji Kubo
Journal:  Asian Pac J Cancer Prev       Date:  2020-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.